| Format | Example | Percentage |
|---|---|---|
| Format:lastName_firstName | doe_jane@accelbio.com | Percentage:81% |
| Format:firstNameInitiallastName | jdoe@accelbio.com | Percentage:12% |
| Format:firstName-lastName | jane-doe@accelbio.com | Percentage:3% |
| Format:firstNameInitial_lastNameInitial | j_d@accelbio.com | Percentage:2% |
| Format:lastNameInitial.firstName | d.jane@accelbio.com | Percentage:1% |
| Format:lastNamefirstName | doejane@accelbio.com | Percentage:1% |
AccelBio employee email verification for instant deliverability checks.
AccelBio is a biotechnology organization founded in 2013 and headquartered in Farmingdale, New York. The company operates with a team of 10 to 50 professionals and reports annual revenue between $1 million and $10 million.
Leadership is driven by Pavel Iserovich, who serves as Senior Research Scientist; Evan Jacobs holds the position of Principal Scientist; and Gregory Kolker works as a Research Associate. These individuals steer research initiatives across the biotech sector.
Since its inception, AccelBio has cultivated a collaborative environment where a modest‑sized team of scientists advances scientific projects within the biotech field. The company’s revenue range reflects its focused niche and ongoing commitment to innovative research outcomes.
AccelBio uses 6 email formats across its organization. The most common pattern is lastName_firstName (e.g., doe_jane@accelbio.com), used in approximately 81% of work addresses.
AccelBio currently employs over 10-50 people from United States, with a head office in Farmingdale, New York, US.
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
